2012
DOI: 10.1093/ajcp/138.suppl1.335
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Novel Immunohistochemical Markers in Renal Cell Carcinoma, Unclassified

Abstract: Routine hormone receptor protein and human epidermal growth factor receptor 2 (HER2) oncoprotein analysis on invasive breast carcinomas provide therapeutic, predictive, and prognostic values and have revealed clinically significant subgroups. The best characterized of these have been designated luminal A, luminal B, HER2, and the so-called triple-negative tumors. The aim of this study was to determine the expression of basal cytokeratins and epidermal growth factor receptor (EGFR) in triple-negative invasive b… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles